RELVAR® 100 ELLIPTA® Special Drug Use Investigation (COPD, Long-term)
NCT03219255
·
clinicaltrials.gov ↗
COMPLETED
Status
1047
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG:
RELVAR 100 ELLIPTA
Sponsor
GlaxoSmithKline